Advancing MR-guided Radiotherapy Together
We are excited to announce that Medscint will be participating in the 11th Annual Symposium on Magnetic Resonance in Radiation Therapy (MRinRT), taking place April 14-16, 2025, at NYU Langone Health in Midtown Manhattan, New York City. This premier event brings together leading specialists and innovators from around the world, focused on the rapidly evolving integration of MRI into radiation oncology.
Engage Directly with Our CEO and Co-founder
Francois Therriault-Proulx PhD, CEO and Co-founder of Medscint, will attend the symposium to discuss the latest advancements in the field and how our HYPERSCINT scintillation detector solutions can dramatically enhance the precision and effectiveness of MR-guided radiotherapy.
This is an excellent opportunity to exchange insights directly with François, explore collaboration opportunities, and understand how scintillation technology is setting new standards in modern radiotherapy.
Why MR-guided Radiotherapy?
Magnetic Resonance-guided Radiotherapy (MRgRT) has emerged as a revolutionary approach, enabling real-time adaptive treatments and improved patient outcomes. However, accurate dosimetry remains a critical challenge, particularly when managing complex motion such as respiratory and cardiac movements.
Medscint’s Innovative Solutions for MRgRT
Medscint’s HYPERSCINT detectors offer exceptional precision through simultaneous spatial, temporal, and motion-integrated dosimetry. Our unique hyperspectral technology allows real-time differentiation between scintillation and Cherenkov emissions, significantly improving measurement accuracy. Recent validation studies confirm that HYPERSCINT substantially enhances adaptive treatment safety and efficacy, supporting MR-Linac and advanced radiotherapy modalities.
Explore more details from our recent research collaborations, including our projects with leading institutions such as UMC Utrecht and the University of Wisconsin–Madison, and discover how our technology contributes to the forefront of radiation oncology.
Medscint is already working with renowned collaborators from the field, discover results of their work :
Join the Conversation
We look forward to meeting you at MRinRT 2025. Don’t miss the opportunity to discuss with François how Medscint is driving innovations that help clinicians deliver safer, more effective radiotherapy.
📅 Date: April 14-16, 2025
📍 Location: NYU Langone Health, Midtown Manhattan, NYC
🔗 Learn more about MRinRT 2025